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Antibiotic Use in a Brazilian City
F. Del Fiol ∗, S. Barberato Filho
University of Sorocaba, Sorocaba, Brazil
The indiscriminate use of antibiotics has contributed to
increase the antimicrobial resistance around the world. In
Brazil, there is no control regarding antibiotics use, once it
is possible to obtain any antibiotic without medical prescrip-
tion. The aim of the present study was to observe the quality
of the antibiotics use (prescription, orientation and use) in
a large Brazilian city. A survey (50 questions) were divided
into three parts: (1) questions about medical appointment
and prescription; (2) about patients’ pathology; (3) about
the level of information of the patient regarding antibi-
otics. 403 patients answered right before they received the
antibiotics. 3 pharmacies were included in the sample: (a)
commercial; (b) public; (c) University’s pharmacy. 28% of
the patients aged from 0 to 10 years-old, 71% of the medi-
cal appointments were performed in the free-public healthy
service and 40% of the person responsible for giving antibi-
otics to the children had less than four years of scholarity.
21% of all users have been using other drugs that could
cause drug interactions and induce therapeutic failure (51%
of patients aging 60 years or more have been using other
drugs). 40% of the patients did not complete the antibiotic
course due to economical reasons and 20% due to disappear-
ance of symptoms (fever). The majority of patients used
water to ingest the drug, but 32% used milk. 60% of the
patients did not present fever during the medical appoint-
ment. 15% did not receive any medical orientation regarding
antibiotic use. The information level of the patients regard-
ing antibiotics was 50% of correct answers, which shows
the deﬁciency of knowledge of the doctors and patients
regarding this issue. We concluded that the necessity of
educational campaigns to inform the medical staff and the
patients is very urgent in order to promote the rational use of
antibiotics and to inhibit the bacterial resistance. Supported
by FAPESP.
doi:10.1016/j.ijid.2008.05.1053
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Bacterial Resistance in Argolis, Greece
K. Mitrakou, I. Mitrakos, G.C. Michalopoulos, E. Xounta, G.
Mavras, M. Pavlaki, F. Rozi ∗
General Hospital of Argos, Greece, Argos, Greece
Objectives: To study the antibiotic resistance in the
microorganisms isolated from blood cultures at the Gen-
eral Hospital of Argos, Greece during the period 01/01/05
to 31/10/2007.
Methods: 791 blood cultures were studies. The iden-
tiﬁcation and the antimicrobial susceptibility tests were
performed using the analysis Bact/ALERT and the automat
system VITEK 2 compact (BIOMERIEUX).
Results: From the 791 blood cultures 661(83,56%) were
negative and 130(16,43%) were positive. CONS-coagulase
negative staphylococci were the most common isolated
bacteria [50 samples (38,46%)], followed by E. coli [25 sam-
ples (19,23%)], Brucella melitensis [21 samples (16,15%)],
Staphylococcus aureus [12 samples(9,23%)], Pseudomonas
auroginosa [7 samples (5,38%)], Klebsiella pneumoniae [3
samples (2,3%)], Enterobacter cloacae [3 samples (2,3%)],
Enterococcus faecalis [2 samples (1,53%)]. The resistance
of E. coli to Ampicillin, Amoxicylin/clavulanic, ciproﬂoxacin
and 3rd generation cephalosporins were 36%, 12%, 8% and
0% respectively. CONS and Staphylococcus aureus presented
48% and 16,66% resistance to Oxacillin respectively and
0% resistance to Vancomycin. Pseudomonas aureginosa pre-
sented 28,57% resistance to ceftazidime, aminoglycosides
and imipenem and 42,85% resistance to ciproﬂoxacin and
piperacillin. For Klebsiella pneumoniae the resistance rate
was 0% to imipenem, 33,33% to aminoglycosides, 66,66%
to ciproﬂoxacin and 3rd generarion cephalosporins. The
enterococcus faecalis strains presented 0% resistance to van-
comycin and linezolid.
Conclusions: Comparing these results to those of EARSS
(European Antimicrobial Resistance Surveillance System),
2006, was observed that the antibiotic resistance preva-
lence of E. coli was lower in this region than that of the
rest of Greece and European countries (ﬂuoroquinolones 8%
in Argolis, 14,5% in Greece, 29,2% in Germany, 28% in Spain,
13,8% in France, for cephalosporins in Argolis 0%, in Greece
6,1%, UK 7,7%, Italy 7,4%). The resistance to vancomycin of
Staphylococcus aureus 0% is similar to that seen in European
countries. Pseudomonas auroginosa and Klebsiella pneumo-
niae presented signiﬁcant resistance rate to other countries.
Greece has the higher resistance rate to imipenem, 47,6%
for pseudomonas and 32,9% for Klebsiella and also to Cef-
tazidime for Pseudomonas 34,1% but in Argolis it was 28,57%
resistance to imipenem for Pseudomonas, 0% for Klebsiella
and 28,57% resistance of Pseudomonas to ceftazidim.
doi:10.1016/j.ijid.2008.05.1054
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Prevalence of Integrons in Malaysian Isolates of Antibiotic
Resistant Bacteria
S.Y. Chia1, S. Muniandy1,∗, N. Parasakthi 2
1 University of Malaya, Kuala Lumpur, Malaysia
2 University of Monash, Kuala Lumpur, Malaysia
Integrons are capable of scavenging transcriptionally
silent antibiotic resistance gene cassettes and converting
them into functional genes. This study characterizes the
resistance gene cassettes carried by integrons in clinical iso-
lates of multiresistant Enterobacteriaceae. Class 1 integrons
were shown to be present in 34 out of the 38 multire-
sistant strains by PCR screening for the intI1 gene. The
qacE1 & sul1 genes were present in 28 of these strains. PCR
ampliﬁcation of the 5′- and 3′-conserved segments, close to
the gene cassette crossover points showed that 23 of the
intI1-positive strains carried an integron with inserted gene
cassettes in their variable regions. The full sequences of the
inserted gene cassettes were studied by restriction mapping
and gene cassettes were classiﬁed into 8 groups. Represen-
tative gene cassettes of each group were then sequenced.
Gene cassettes were found to carry genes encoding resis-
tance to streptomycin and spectinomycin (aadA1, aadA2,
aadA5 and aadB), trimethoprim (dfrA1, dfrA15, dfr16, dfr17
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& dhfrXII) and chloramphenicol (catB3) and correlated to
their antimicrobial susceptibility phenotypes. A new combi-
nation of gene cassettes (dfrA15- aadA1) was found in one
of the strains studied. The complete sequences of these
gene cassettes have been submitted to the GenBank and
Accession Numbers have been assigned.
doi:10.1016/j.ijid.2008.05.1055
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Risk Factors for Nephrotoxicity associated with Con-
tinuous Vancomycin Infusion in Outpatient Parenteral
Antibiotic Therapy
P.R. Ingram1, D.C. Lye2, P.A. Tambyah1, W.P. Goh2, V.H.
Tam3,∗, D.A. Fisher1
1 National University Hospital, Singapore, Singapore
2 Tan Tock Seng Hospital, Singapore, Singapore
3 University of Houston, Houston, TX, USA
Background: Continuous vancomycin infusion is increas-
ingly used for outpatient management of infections, but the
relationship between vancomycin and nephrotoxicity is con-
troversial. We investigated the risk factors associated with
nephrotoxicity in this setting.
Methods: A retrospective cohort study of patients receiv-
ing continuous vancomycin infusion as Outpatient Parenteral
Antibiotic Therapy (OPAT) was performed. The likelihood
of developing nephrotoxicity (≥50% increase in serum
creatinine from baseline) was evaluated in relation to
demographic variables, underlying co-morbidities, infec-
tious disease diagnoses, concomitant drug exposures and
vancomycin concentration. Logistic regression was used to
determine the association of various variables. Classiﬁcation
and regression tree analysis was used to determine the most
signiﬁcant breakpoint for continuous variables.
Results: We examined 102 adult patients between Jan-
uary 2004 and June 2007. The mean± SD age, baseline
serum creatinine and steady state vancomycin concen-
tration were 48.2± 17.6 years, 78.0± 32.5mol/L and
15.5± 10.8mg/L, respectively. The majority of the patients
(66.7%) were treated for bone and joint infection.
The cumulative incidence of nephrotoxicity was 15.7%.
Nephrotoxicity was found to be associated with hyper-
tension [odds ratio (OR) 5.302 (95% conﬁdence interval
{CI}1.159—24.246), p = 0.031], exposure to aminoglycosides
[OR 6.594 (95% CI 1.026—42.385), p = 0.047], loop diuret-
ics [OR 8.123 (95% CI 1.449—45.528), p = 0.017], and steady
state vancomycin concentration≥ 28mg/L [OR 21.236 (95%
CI 2.687—167.857), p = 0.004].
Conclusion: We have identiﬁed independent risk factors
for nephrotoxicity in patients receiving continuous infusion
vancomycin in OPAT. A serum steady state vancomycin con-
centration≥ 28mg/L markedly increases this risk.
doi:10.1016/j.ijid.2008.05.1056
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Comparative Study of Piperacillin/Tazobactam and
Cefepime in Cancer Patients with Febrile Neutropenia
Y.M. Wi ∗, D.R. Chung, J.H. Song, K.R. Peck
Samsung Medical Center, Seoul, Republic of Korea
Background: To compare the efﬁcacy and safety of
piperacillin/tazobactam with cefepime as an empiri-
cal monotherapy for adult cancer patients with febrile
neutropenia. Method: A prospective, randomized, open-
labelled, comparative trial was performed. If clinically
preferable, the test article may be changed to oral
ciproﬂoxacin at 72 hours. Clinical and microbiological
responses were determined at 72 hours and at the end of
therapy.
Results: A total of 89 cases were enrolled. 48 patients
received piperacillin/tazobactam (PT group) and 41 patients
received cefepime (CA group). Demographic and clinical
characteristics were similar in two groups (p > 0.05). Clin-
ical success rate at 72 hours in PT group (91.7%) was similar
to that in CA group (85.4%) (p = 0.31). At the end of therapy,
clinical success rate in PT group (91.7%) was also similar to
that in CA group (100%) (p = 0.15). Adverse events including
liver dysfunction (21.3%) and renal dysfunction (2.2%) were
similar in two groups (p = 0.87).
Conclusion: piperacillin/tazobactammonotherapy was as
effective and safe as the cefepime as an empirical treatment
for cancer patients with febrile neutropenia.
doi:10.1016/j.ijid.2008.05.1057
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Bioprospecting for Antimicrobial Peptides
K. Philip ∗, S.K. Sinniah, S. Muniandy
University of Malaya, Kuala Lumpur, Malaysia
Cationic antimicrobial peptides (AMPs) are important
mediators in the primary host defense system against
pathogenic microorganisms and are widely distributed
in nature. The occurrence and characterization of low-
molecular-mass AMPs from a wide variety of organisms have
been accumulating at a rapid rate because of their biochem-
ical diversity and broad speciﬁcity against bacteria or fungi
and even some being anti-viral or possessing wound-healing
effects. This has biopharmaceutical applications especially
in view of the increased bacterial resistance to antibiotics in
the clinical setting over the past decade. There is a growing
need to discover and introduce new drugs, and AMPs provide
new promising candidates as new antibiotics. The objective
of this study has been to isolate novel peptides from native
microbial and plant sources including fermented extracts.
The antimicrobial properties of these extracts were ini-
tially tested using Escherichia coli, Staphylococcus aureus
and Bacillus subtilis. This paper shows the initial results of
the inhibition obtained on these microorganisms using plant
and fermented extracts. The extracts were fractionated
using cation exchange chromatography and antimicrobial
tests were conducted with the fractions obtained. High pres-
sure liquid chromatography was attempted with one of the
extracts and some preliminary results were also obtained.
